Related Experiment Videos
3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agents
B R Henke1, T M Willson, E E Sugg
1Glaxo Wellcome Research and Development, Research Triangle Park, North Carolina 27709, USA. henkebr@glaxo.com
Journal of Medicinal Chemistry
|July 5, 1996
Abstract
No abstract available in PubMed .